Work

Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection--United States, 2003.

Year: 2003
Type: other
Source: PubMed
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W4299575429
Cites:
Cited by: 108
Related to: 10